Skip to content

The Medasense Study

Measurement of Nociceptive Index During General Anesthesia in ASA 1-3 Patients Undergoing Elective Surgery Using the Nociception Level (NoL) Index

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01912118
Enrollment
96
Registered
2013-07-30
Start date
2013-07-31
Completion date
2014-09-30
Last updated
2015-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Nociception, General anesthesia

Brief summary

Despite various efforts there is still the need for adequate monitoring of pain and nociception during anesthesia. In a previous protocol the investigators measured pain responses during anesthesia based on single end-points, eg heart rate,blood pressure and pulse transit time. None of these parameters provided sufficient information regarding nociception. The investigators therefore want to further investigate this matter using a composite parameter, the Nociception Level or NoL. The NoL is a novel index that measures the magnitude of the autonomic response to painful stimuli. The NoL combines information from several physiological parameters, which represent different autonomic pathways. The multi-parameter approach empowered with state-of-the-art signal processing and machine learning techniques. In the current study the investigators will measure the NoL in ASA 1-3 patients undergoing elective surgery under general anesthesia. The investigators will measure NoL responses and the occurrence of patient movement upon the administration of a painful stimulus: Introduction of the laryngoscope, Insertion of the endotracheal tube, Insertion of the gastric tube, Insertion of the bladder catheter and Skin incision.

Interventions

DRUGPropofol

Propofol will be titrated via a target controlled infusion to reach a specific target BIS (as specified in treatment arm)

DRUGRemifentanil

Remifentanil will be provided by a target controlled infusion to a specific effect site concentration (as specified in treatment arm)

Sponsors

Medasense Biometrics Ltd
CollaboratorOTHER
Leiden University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18-80 years; * Sex: male or female; * Surgery: Any surgery under general anesthesia; * ASA status: 1, 2 or 3.

Exclusion criteria

* Age: \< 18 or \> 80 years; * Unable to give written informed consent; * Pregnancy/lactation; * Extreme obesity: BMI \> 35; * Perceived difficult intubation. * Patients requiring a rapid sequence induction * Patients on beta-blockers

Design outcomes

Primary

MeasureTime frameDescription
Nociception level index (NoI)Between induction and first incisionThe NoL measures the magnitude of the autonomic responses to painful stimuli. The NoL combines information from several physiological parameters which represent different autonomic pathways.

Secondary

MeasureTime frameDescription
Cardiovascular parametersBetween induction and first incisionIndividual pain related cardiovascular parameters, as heart rate, blood pressure and PPG wave amplitude.
MovementBetween induction and first incisionVisible occurence of movement during painfull stimuli.
Depth of anesthesiaBetween induction and first incisionDepth of anesthesia is measured by a Bispectral Index monitor. Changes in depth of anesthesia will be recorded during painfull stimuli

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026